Cargando…
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
KRAS is the most commonly mutated oncogene in human cancers. Targeted therapy and immunotherapy for this gene have made remarkable progress in recent years. However, comprehensive molecular landscape analysis of KRAS in rare tumors is lacking. Retrospective analysis was performed on clinical samples...
Autores principales: | Wang, Shuhang, Li, Qin, Ma, Peiwen, Fang, Yuan, Yu, Yue, Jiang, Ning, Miao, Huilei, Tang, Qiyu, Yang, Yuqi, Xing, Shujun, Chen, Rongrong, Yi, Xin, Li, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962378/ https://www.ncbi.nlm.nih.gov/pubmed/35359599 http://dx.doi.org/10.3389/fmolb.2022.831382 |
Ejemplares similares
-
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
por: Wang, Shuhang, et al.
Publicado: (2022) -
Characterization of the Immune Cell Infiltration Landscape of Thyroid Cancer for Improved Immunotherapy
por: Gong, Jing, et al.
Publicado: (2021) -
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022) -
Free Energy Profiles Relating With Conformational Transition of the Switch Domains Induced by G12 Mutations in GTP-Bound KRAS
por: Chen, Jianzhong, et al.
Publicado: (2022) -
3453 The Spectrum of Homelessness and Its Association with Maternal Morbidity
por: Robinson, Kelley N., et al.
Publicado: (2019)